Notice of AGM

RNS Number : 3043L

Futura Medical PLC

24 April 2015

 

For immediate release

24 April 2015

Futura Medical plc

("Futura" or "the Company")

Notice of AGM

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces that its notice of Annual General Meeting ("AGM"), including Explanatory Notes and Form of Proxy, has today been posted to shareholders. The AGM will be held at 4.00pm on 17 June 2015 at the offices of Buchanan, 107 Cheapside, London EC2V 6DN.

Futura's annual report and accounts for the year ended 31 December 2014 is available to shareholders as an electronic communication pursuant to the Companies Act 2006 and is available at the Company's website www.futuramedical.com.

Shareholders who would like to attend the AGM are invited to contact Buchanan on 020 7466 5000 or to email [e-mail].

For any further information please contact:

Futura Medical plc
James Barder, Chief Executive	Tel: [phone]
mail to: [e-mail]	www.futuramedical.com
N+1 Singer (Nominated Adviser and Broker)
Aubrey Powell / Thomas Smale - Corporate Finance Brough Ransom - Sales	Tel:[phone]
For media enquiries please contact:
Buchanan
Mark Court / Sophie Cowles / Stephanie Watson	Tel: [phone]

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

 

END

 

 

NOAUSVORVOASUAR